Literature DB >> 22386837

The genetic basis of kidney cancer: implications for management and use of targeted therapeutic approaches.

W Marston Linehan.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22386837      PMCID： PMC4446720          DOI： 10.1016/j.eururo.2012.02.022

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  9 in total

Review 1.  The genetic basis of kidney cancer: a metabolic disease.

Authors:  W Marston Linehan; Ramaprasad Srinivasan; Laura S Schmidt
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

2.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

3.  The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels.

Authors:  Wing-Hang Tong; Carole Sourbier; Gennady Kovtunovych; Suh Young Jeong; Manish Vira; Manik Ghosh; Vladimir Valera Romero; Rachid Sougrat; Sophie Vaulont; Benoit Viollet; Yeong-Sang Kim; Sunmin Lee; Jane Trepel; Ramaprasad Srinivasan; Gennady Bratslavsky; Youfeng Yang; W Marston Linehan; Tracey A Rouault
Journal:  Cancer Cell       Date:  2011-09-13       Impact factor: 31.743

Review 4.  Lymphatic system: a vital link between metabolic syndrome and inflammation.

Authors:  Sanjukta Chakraborty; Scott Zawieja; Wei Wang; David C Zawieja; Mariappan Muthuchamy
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

5.  Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation.

Authors:  Nils Kroeger; Edward N Rampersaud; Jean-Jacques Patard; Tobias Klatte; Frédéric D Birkhäuser; Shahrokh F Shariat; Hervé Lang; Nathalie Rioux-Leclerq; Mesut Remzi; Nazy Zomorodian; Fairooz F Kabbinavar; Arie S Belldegrun; Allan J Pantuck
Journal:  J Urol       Date:  2011-12-15       Impact factor: 7.450

6.  Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.

Authors:  Michael L Nickerson; Erich Jaeger; Yangu Shi; Jeffrey A Durocher; Sunil Mahurkar; David Zaridze; Vsevolod Matveev; Vladimir Janout; Hellena Kollarova; Vladimir Bencko; Marie Navratilova; Neonilia Szeszenia-Dabrowska; Dana Mates; Anush Mukeria; Ivana Holcatova; Laura S Schmidt; Jorge R Toro; Sara Karami; Rayjean Hung; Gary F Gerard; W Marston Linehan; Maria Merino; Berton Zbar; Paolo Boffetta; Paul Brennan; Nathaniel Rothman; Wong-Ho Chow; Frederic M Waldman; Lee E Moore
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

Review 7.  The genetic basis of cancer of the kidney.

Authors:  W Marston Linehan; McClellan M Walther; Berton Zbar
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

8.  Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma.

Authors:  Ignacio Varela; Patrick Tarpey; Keiran Raine; Dachuan Huang; Choon Kiat Ong; Philip Stephens; Helen Davies; David Jones; Meng-Lay Lin; Jon Teague; Graham Bignell; Adam Butler; Juok Cho; Gillian L Dalgliesh; Danushka Galappaththige; Chris Greenman; Claire Hardy; Mingming Jia; Calli Latimer; King Wai Lau; John Marshall; Stuart McLaren; Andrew Menzies; Laura Mudie; Lucy Stebbings; David A Largaespada; L F A Wessels; Stephane Richard; Richard J Kahnoski; John Anema; David A Tuveson; Pedro A Perez-Mancera; Ville Mustonen; Andrej Fischer; David J Adams; Alistair Rust; Waraporn Chan-on; Chutima Subimerb; Karl Dykema; Kyle Furge; Peter J Campbell; Bin Tean Teh; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2011-01-19       Impact factor: 49.962

9.  Reductive carboxylation supports growth in tumour cells with defective mitochondria.

Authors:  Andrew R Mullen; William W Wheaton; Eunsook S Jin; Pei-Hsuan Chen; Lucas B Sullivan; Tzuling Cheng; Youfeng Yang; W Marston Linehan; Navdeep S Chandel; Ralph J DeBerardinis
Journal:  Nature       Date:  2011-11-20       Impact factor: 69.504
  9 in total
  7 in total

1.  Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program.

Authors:  Brian Shuch; Jonathan N Hofmann; Maria J Merino; Jeffrey W Nix; Srinivas Vourganti; W Marston Linehan; Kendra Schwartz; Julie J Ruterbusch; Joanne S Colt; Mark P Purdue; Wong-Ho Chow
Journal:  Urol Oncol       Date:  2013-02-28       Impact factor: 3.498

2.  Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy.

Authors:  Lisha Wang; Sean R Williamson; Mingsheng Wang; Darrell D Davidson; Shaobo Zhang; Lee Ann Baldridge; Xiang Du; Liang Cheng
Journal:  Mol Cancer       Date:  2014-02-26       Impact factor: 27.401

3.  MiR-935 Promotes Clear Cell Renal Cell Carcinoma Migration and Invasion by Targeting IREB2.

Authors:  Fei Liu; Yuedong Chen; Bin Chen; Chunxiao Liu; Jinchun Xing
Journal:  Cancer Manag Res       Date:  2019-12-30       Impact factor: 3.989

4.  cg04448376, cg24387542, cg08548498, and cg14621323 as a Novel Signature to Predict Prognosis in Kidney Renal Papillary Cell Carcinoma.

Authors:  Ying-Lei Wang; Ying-Ying Zhang
Journal:  Biomed Res Int       Date:  2020-12-17       Impact factor: 3.411

5.  miR-363 suppresses the proliferation, migration and invasion of clear cell renal cell carcinoma by downregulating S1PR1.

Authors:  Yongpeng Xie; Luyao Chen; Yu Gao; Xin Ma; Weiyang He; Yu Zhang; Fan Zhang; Yang Fan; Liangyou Gu; Pin Li; Xu Zhang; Xin Gou
Journal:  Cancer Cell Int       Date:  2020-06-10       Impact factor: 5.722

6.  MiR-223-3p promotes cell proliferation and metastasis by downregulating SLC4A4 in clear cell renal cell carcinoma.

Authors:  Wen Xiao; Xuegang Wang; Tao Wang; Jinchun Xing
Journal:  Aging (Albany NY)       Date:  2019-01-22       Impact factor: 5.682

7.  Low DAPK1 expression correlates with poor prognosis and sunitinib resistance in clear cell renal cell carcinoma.

Authors:  Zhengshuai Song; Zhongyuan Li; Weiwei Han; Chenxi Zhu; Ning Lou; Xuechao Li; Gang Luo; Song Peng; Guohao Li; Ye Zhao; Yonglian Guo
Journal:  Aging (Albany NY)       Date:  2020-11-16       Impact factor: 5.682
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.